-
J. Thorac. Cardiovasc. Surg. · Apr 2016
Mitral valve-in-valve hemodynamic performance: An in vitro study.
- Morgane Evin, Carine Guivier-Curien, Regis Rieu, Josep Rodés-Cabau, and Philippe Pibarot.
- Aix-Marseille Université, CNRS, ISM UMR 7287, 13288 Marseille cedex 09, France; Protomedlabs, Marseille, France. Electronic address: evinmorgane@gmail.com.
- J. Thorac. Cardiovasc. Surg. 2016 Apr 1; 151 (4): 1051-9.e6.
ObjectivesThe valve-in-valve (VinV) procedure may be used in high-risk patients with failed mitral surgical bioprostheses. The objective of this in vitro study was to assess the hemodynamic function of different VinV configurations.MethodsA double activation duplicator was used to test 11 valve configurations (surgical bioprostheses alone) and 15 VinV configurations (Sapien [Edwards Lifesciences, Irvine, Calif] implanted within the surgical bioprosthesis) under 8 different hemodynamic conditions. The internal orifice diameter (IOD) of the surgical bioprosthesis was measured with a Smartscope (OGP Multi Sensor Measuring Instruments, Singapore).ResultsThe VinV procedure was associated with significant deterioration in antegrade hemodynamic parameters compared with valve configuration (effective orifice area, 1.51 ± 0.21 cm(2) vs 1.65 ± 0.37 cm(2); P < .001 and regurgitant fraction, 11.5% ± 7.2% vs 4.8% ± 3.8%; P < .001). Among the 120 tested experimental VinV situations, moderate or greater mitral stenosis occurred in 52 situations and mild or greater regurgitation occurred in 28 situations. The IOD of the surgical bioprosthesis was the main independent determinant of effective orifice area and regurgitant fraction. An IOD < 22 mm was associated with higher risk of significant mitral stenosis, particularly when the oversizing was >20%, and IOD > 23 mm was associated with higher risk of paravalvular regurgitation when oversizing was <8%.ConclusionsThis in vitro study shows that VinV within mitral surgical bioprostheses provides satisfactory hemodynamic results in the majority of patients. However, significant mitral stenosis is more likely to occur when the IOD of the surgical bioprosthesis is <22 mm, and particularly when the percentage of oversizing is >20%. Significant paravalvular regurgitation is rare and occurs with larger IODs and lower percentage of oversizing (8%).Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.